Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

PHASE3CompletedINTERVENTIONAL
Enrollment

441

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

April 30, 2005

Study Completion Date

June 30, 2005

Conditions
Essential Hypertension
Interventions
DRUG

olmesartan medoxomil + hydrochlorothiazide, if necessary

oral olmesartan medoxomil tablets taken once daily for 52 weeks + oral hydrochlorothiazide tablets, once daily, after 12 weeks if needed to control BP

DRUG

losartan + hydrochlorothiazide, if necessary

oral losartan capsules, 50 or 100 mg taken once daily for 52 weeks + 12.5 or 25 mg oral hydrochlorothiazide tablets, after 12 weeks, if needed to control BP.

Trial Locations (1)

Unknown

Darmstadt

All Listed Sponsors
lead

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

INDUSTRY

NCT00751751 - Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly | Biotech Hunter | Biotech Hunter